Evidence map›Paper›PMID 37869380›Full record

ArticleRSC advances2023

Composite ligand shells on gold nanoprisms - an ensemble and single particle study.

Dániel Zámbó, Dávid Kovács, Gergely Südi, Zsolt Zolnai, András Deák

Abstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dániel ZámbóCentre for Energy Research Konkoly-ThegeM. Str. 29-33 Budapest 1121 Hungary andras.deak@ek.hun-ren.hu.ORCID https://orcid.org/0000-0001-7671-039X
Dávid KovácsCentre for Energy Research Konkoly-ThegeM. Str. 29-33 Budapest 1121 Hungary andras.deak@ek.hun-ren.hu.ORCID https://orcid.org/0000-0002-9019-0754
Gergely SüdiCentre for Energy Research Konkoly-ThegeM. Str. 29-33 Budapest 1121 Hungary andras.deak@ek.hun-ren.hu.
Zsolt ZolnaiCentre for Energy Research Konkoly-ThegeM. Str. 29-33 Budapest 1121 Hungary andras.deak@ek.hun-ren.hu.
András DeákCentre for Energy Research Konkoly-ThegeM. Str. 29-33 Budapest 1121 Hungary andras.deak@ek.hun-ren.hu.ORCID https://orcid.org/0000-0002-2526-1245

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The attachment of thiolated molecules onto gold surfaces is one of the most extensively used and robust ligand exchange approaches to exploit the nanooptical features of nanoscale and nanostructured plasmonic materials. In this work, the impact of thiol adsorption on the optical properties of wet-chemically synthesized gold nanoprisms is studied both at the ensemble and single particle level to investigate the build-up of more complex ligand layers. Two prototypical ligands with different lengths have been investigated ((16-mercaptohexadecyl)trimethylammonium bromide - MTAB and thiolated polyethylene glycol - mPEG-SH). From ensemble experiments it is found that composite ligand layers are obtained by the sequential addition of the two thiols, and an island-like surface accumulation of the molecules can be anticipated. The single particle experiment derived chemical interface damping and resonance energy changes further support this and show additionally that when the two thiols are used simultaneously, a higher density, intermixed layer is formed. Hence, when working with more than a single type of ligand during surface modification, sequential adsorption is preferred for the combination of accessible essential surface functionalities, whereas for high overall loading the simultaneous use of the different ligand types is favourable.

Identifiers

PMID37869380
PMCPMC10585614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.